Cargando…
EHMTI-0223. Botox in the prevention of chronic migraine; 18-months follow up outcome in 67 patients
Autores principales: | Khalil, M, Zafar, H, Ahmed, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182188/ http://dx.doi.org/10.1186/1129-2377-15-S1-G1 |
Ejemplares similares
-
EHMTI-0090. Botox in the prevention of chronic migraine; comparing NICE criteria versus hull criteria for evaluating responder rate
por: Zafar, H, et al.
Publicado: (2014) -
EHMTI-0102. Prospective analysis of the use of onabotulinumtoxina (botox®) In the treatment of chronic migraine; real-life data in 299 patients from hull, UK
por: Khalil, M, et al.
Publicado: (2014) -
EHMTI-0146. Topiramate in migraine prevention
por: Ristic, S, et al.
Publicado: (2014) -
EHMTI-0108. Efficacy of therapy in patients with migraine: comparison in group of < 9 migraines and > 10 migraines per month
por: Cvetkovic, V Vukovic, et al.
Publicado: (2014) -
EHMTI-0133. Does medication overuse matter? Response to botulinum toxin type A in chronic migraine in patients with or without medication overuse
por: Zafar, H, et al.
Publicado: (2014)